Standard Ibuprofen
Phase 3Small molecule
PfizerStandard Ibuprofen is one of 14 small molecule programs targeting Headache. It is currently in Phase 3.
2
Indications
4
Total Trials
0
Active Trials
13
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
17 competitors in Tension-Type Headache
#DrugCompanyPhaseTrials
1Bayer Aspirin
BayerApproved
Reglan
IIstituto Clinico Humanitas
Approved
Advil
KKenvue Brands
Approved
Toradol
JJavelin Pharmaceuticals
Approved
Tylenol
KKenvue Brands
Approved
Alka-Seltzer
AAbbott
Approved
Acetylsalicylic Acid
BayerApproved
Namenda
AbbViePhase 3
Botox
VVitae Pharmaceuticals Inc., an Allergan affiliate
Phase 3
Novel Ibuprofen
PfizerPhase 3
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Ibuprofen1 trial
Tension-type headache1 trial
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Standard Ibuprofen. EMBL-EBI & Wellcome Sanger Institute.
- [4]